课题基金 / 基金详情

Coordinate expression of virulence factors in pathogenic Escherichia coli

Coordinate expression of virulence factors in pathogenic Escherichia coli
致病性大肠杆菌毒力因子的协调表达
批准号:
nhmrc : 301163
负责人:
Prof Mark Schembri
金额:
$15.95万
依托单位:
依托单位国家:
澳大利亚
项目类别:
NHMRC Project Grants
财政年份:
2004
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2004-01-01 至 2006-12-31

项目摘要

项目成果

Prof Mark Schembri的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Escherichia coli is a versatile pathogen capable of causing a range of disease types including diarrhoea, dysentery, haemolytic uremic syndrome, bladder and kidney infections, septicaemia, pneumoniae and meningitis. Infections due to pathogenic E. coli may be limited to mucosal surfaces or can disseminate throughout the body. Amongst the different classes of pathogenic E. coli, diarrheagenic strains (namely enterotoxigenic and enteroinvasive E. coli) are responsible for the death of an estimated one million humans per year, mainly in third world countries. The majority (80%) of urinary tract infections (UTIs) in humans are caused by E. coli and in Australia alone there are about 250,000 cases per year. It is estimated that one in four women and one in twenty men will develop a urinary tract infection in their lifetime. Pathogenic E. coli strains are normally equipped with multiple virulence factors and there is mounting evidence that the expression of such factors is finely orchestrated by mutual regulatory cross-talk. For example, expression of flagella (which provide motility) and adhesins (which provide attachment) are fundamentally counteracting phenotypes, yet the molecular and genetic mechanisms that coordinate their expression are unknown. I plan to examine inter-system cross-regulation of bacterial surface structures (namely adhesins, autoaggregaters, capsules and flagella). The aim is to understand on the molecular level how microorganisms orchestrate expression of virulence factors and will have consequences for our understanding of microbial pathogenicity. The strategy outlined may lead to new routes for strain attenuation and perhaps a method for vaccine strain construction. The research will be performed in collaboration with international high profile partners.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Untangling the matrix of bacterial biofilms
  • 批准号:
    DP230101930
  • 项目类别:
    Discovery Projects
  • 资助金额:
    $33.22万
  • 财政年份:
    2023
  • 负责人:
    Prof Mark Schembri
  • 依托单位:
The dual-edged sword of zinc as an innate immune antimicrobial weapon against uropathogenic E. coli
  • 批准号:
    nhmrc : GNT1144967
  • 项目类别:
    Project Grants
  • 资助金额:
    $78.44万
  • 财政年份:
    2018
  • 负责人:
    Prof Mark Schembri
  • 依托单位:
The dual-edged sword of zinc as an innate immune antimicrobial weapon against uropathogenic E. coli
  • 批准号:
    nhmrc : 1144967
  • 项目类别:
    Project Grants
  • 资助金额:
    $53.04万
  • 财政年份:
    2018
  • 负责人:
    Prof Mark Schembri
  • 依托单位:
Membrane-active antibiotics against multi-drug resistant Gram negative bacteria
  • 批准号:
    nhmrc : 1106590
  • 项目类别:
    Project Grants
  • 资助金额:
    $64.88万
  • 财政年份:
    2016
  • 负责人:
    Prof Mark Schembri
  • 依托单位:
国内基金
海外基金
缺氧诱导因子(HIF)-2α转录抑制树突状细胞CD36表达减轻肾脏缺血再灌注损伤的机制
  • 批准号:
    82370751
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    张明
  • 依托单位:
内源性蛋白酶抑制剂SerpinA3N对缺血性脑卒中后血脑屏障的保护作用及其表达调控机制
  • 批准号:
    82371317
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    万杰清
  • 依托单位:
22q11.2染色体微重复影响TOP3B表达并导致腭裂发生的机制研究
  • 批准号:
    82370906
  • 项目类别:
    面上项目
  • 资助金额:
    48.00万元
  • 批准年份:
    2023
  • 负责人:
    代杰文
  • 依托单位:
基于FCER1G基因介导免疫反应探讨迟发性聋与认知障碍相关性的机制研究
  • 批准号:
    82371141
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    陈颖
  • 依托单位: